These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14960238)

  • 1. [Expression of survivin in ovarian epithelial carcinoma and its correlation with expression of Fas and FasL].
    Ma XY; He FX; Wu SF; Lu YP; Ma D
    Ai Zheng; 2004 Feb; 23(2):173-6. PubMed ID: 14960238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of survivin, Fas and FasL contributed to cervical cancer development and metastasis.
    Wu SF; Zhang JW; Qian WY; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2044-50. PubMed ID: 23280017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells.
    Asanuma K; Tsuji N; Endoh T; Yagihashi A; Watanabe N
    J Immunol; 2004 Mar; 172(6):3922-9. PubMed ID: 15004200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Fas and FasL in human serous ovarian epithelial tumors.
    van Haaften-Day C; Russell P; Davies S; King NJ; Tattersall MH
    Hum Pathol; 2003 Jan; 34(1):74-9. PubMed ID: 12605369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
    Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.
    Hasby EA
    Pathol Oncol Res; 2012 Apr; 18(2):509-18. PubMed ID: 22161157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors.
    Arts HJ; de Jong S; Hollema H; Ten Hoor KA; de Vries EG; van der Zee AG
    Int J Oncol; 2005 Feb; 26(2):379-84. PubMed ID: 15645122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):773-8. PubMed ID: 16525657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of microtubule-associated protein 1 light chain 3 (LC3) and Beclin1 in epithelial ovarian cancer].
    Shen Y; Liang LZ; Hong MH; Xiong Y; Wei M; Zhu XF
    Ai Zheng; 2008 Jun; 27(6):595-9. PubMed ID: 18570732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin in ovary tumors.
    Plewka D; Jakubiec-Bartnik B; Morek M; Bogunia E; Bienioszek M; Wolski H; Kotrych D; Dziekan K; Seremak-Mrozikiewicz A; Plewka A
    Ginekol Pol; 2015 Jul; 86(7):525-30. PubMed ID: 26376531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Qian X; Xi X; Li L
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):126-32. PubMed ID: 20724919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
    J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of apoptosis and Fas expression of peritoneal fluid and peripheral blood T lymphocytes in patients with epithelial ovarian cancer and their relationship with CA125].
    Ma YX; Ye F; Chen HZ; Lü WG; Xie X
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):734-9. PubMed ID: 17565840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
    Das H; Koizumi T; Sugimoto T; Chakraborty S; Ichimura T; Hasegawa K; Nishimura R
    Br J Cancer; 2000 May; 82(10):1682-8. PubMed ID: 10817504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Fas ligand expression by estrogen in normal ovary.
    Sapi E; Brown WD; Aschkenazi S; Lim C; Munoz A; Kacinski BM; Rutherford T; Mor G
    J Soc Gynecol Investig; 2002; 9(4):243-50. PubMed ID: 12113885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of survivin gene and its relation with the expression of bcl-2 and bax protein in epithelial ovarian cancer].
    Zhang SL; Zhao CQ; Lin B; Li Y; Gao H
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):203-6. PubMed ID: 12885364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.